In other studies, when the imprinting status of H19 and insulin-like growth factors 2 (IGF2) were manipulated, the development of brain tumors including meningiomas, medulloblastomas, and gliomas could be altered [40]. The gene discussed is H19; the disease is medulloblastoma.